39 companies

PharmaEssentia

Market Cap: NT$500.9b

A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.

New

6446

NT$1,335.00

7D

23.6%

1Y

224.1%

Bausch Health Companies

Market Cap: US$2.6b

Operates as a diversified specialty pharmaceutical and medical device company.

New

BHC

US$6.44

7D

42.5%

1Y

8.4%

CareDx

Market Cap: US$2.5b

Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.

New

CDNA

US$47.09

7D

31.7%

1Y

266.5%

Harbin Pharmaceutical Group

Market Cap: CN¥16.2b

Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.

New

600664

CN¥6.77

7D

26.3%

1Y

72.3%

Neuren Pharmaceuticals

Market Cap: AU$2.4b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

New

NEU

AU$21.64

7D

26.3%

1Y

27.2%

Sino BiologicalInc

Market Cap: CN¥10.2b

Engages in the provision of recombinant protein and antibody reagents for life science researchers in China and internationally.

New

301047

CN¥90.60

7D

31.8%

1Y

23.9%

PYC Therapeutics

Market Cap: AU$2.0b

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

New

PYC

AU$2.10

7D

29.2%

1Y

61.5%

Replimune Group

Market Cap: US$1.0b

A clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer in the United States and the United Kingdom.

New

REPL

US$11.92

7D

120.3%

1Y

116.7%

GlaxoSmithKlineE

Market Cap: ج.م34.6b

Engages in production of pharmaceutical chemicals.

New

BIOC

ج.م414.30

7D

107.4%

1Y

756.7%

Egyptian International Pharmaceutical Industries

Market Cap: ج.م25.3b

Manufactures and sells pharmaceutical ampoules in Egypt and internationally.

New

PHAR

ج.م149.76

7D

60.3%

1Y

192.2%

ACRO Biomedical

Market Cap: NT$15.6b

Develops medical-grade regenerative biomaterials in Taiwan, Vietnam, and internationally.

New

6748

NT$207.50

7D

25.0%

1Y

158.4%

Xinjiang Bai Hua Cun Pharma TechLtd

Market Cap: CN¥3.0b

Engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses.

New

600721

CN¥8.71

7D

23.4%

1Y

8.3%

Morepen Laboratories

Market Cap: ₹37.9b

Develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally.

New

500288

₹76.97

7D

33.1%

1Y

44.5%

Agenus

Market Cap: US$371.4m

A clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally.

New

AGEN

US$8.30

7D

25.2%

1Y

74.4%

Anika Therapeutics

Market Cap: US$277.5m

A joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally.

New

ANIK

US$19.61

7D

29.4%

1Y

134.9%

AN2 Therapeutics

Market Cap: US$201.0m

A biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics.

New

ANTX

US$5.94

7D

26.4%

1Y

460.4%

Japan Tissue Engineering

Market Cap: JP¥30.6b

Engages in the regenerative medicine business in Japan.

New

7774

JP¥776.00

7D

28.3%

1Y

38.6%

Fredun Pharmaceuticals

Market Cap: ₹18.4b

Manufactures and sells pharmaceutical formulations, dietary/herbal supplements, nutraceuticals, animal healthcare products, cosmeceuticals, mobility and rehabilitation products, and other healthcare products in India, Africa, Southeast Asia, Commonwealth of Independent States countries, MENA region, and Latin America.

New

539730

₹1,313.30

7D

44.8%

1Y

252.1%

Fermenta Biotech

Market Cap: ₹15.7b

Manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally.

New

506414

₹551.65

7D

22.2%

1Y

56.4%

Nyrada

Market Cap: AU$183.9m

A pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases.

New

NYR

AU$0.74

7D

37.0%

1Y

155.2%

Yarrow Bioscience

Market Cap: US$107.2m

Operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases.

New

YARW

US$37.96

7D

24.6%

1Y

108.0%

JW Shinyak

Market Cap: ₩108.3b

Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.

New

A067290

₩2,005.00

7D

28.0%

1Y

32.4%

Eloxx Pharmaceuticals

Market Cap: US$74.5m

A clinical-stage biopharmaceutical company, develops small-molecule product candidates that modulate the ribosome and promote readthrough of premature stop codons caused by nonsense mutations in the United States, Israel, and Australia.

New

ELOX

US$18.43

7D

43.9%

1Y

1,676,879.1%

BetterLife Pharma

Market Cap: US$39.7m

A biotechnology company, engages in the development of psychedelic-derived compounds.

New

BETR.F

US$0.25

7D

51.5%

1Y

281.7%

Quantum Cyber

Market Cap: US$34.6m

Operates as a technology company focused on cybersecurity and quantum computing solutions.

New

QUCY

US$1.50

7D

41.5%

1Y

2.0%

Ambalal Sarabhai Enterprises

Market Cap: ₹3.3b

Manufactures, markets, and supplies pharmaceutical products in India and internationally.

New

500009

₹43.10

7D

39.5%

1Y

35.1%

EOM Pharmaceuticals Holdings

Market Cap: US$29.7m

A clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States.

New

IMUC

US$0.22

7D

69.1%

1Y

121.3%

Sabaa International Company for Pharmaceutical and Chemical Industry

Market Cap: ج.م1.2b

Operates as a healthcare company in Egypt.

New

SIPC

ج.م4.83

7D

20.4%

1Y

50.5%

Medicure

Market Cap: CA$13.6m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

New

MPH

CA$1.30

7D

25.0%

1Y

17.1%

Vectus Biosystems

Market Cap: AU$8.0m

Engages in the medical research and development activities in Australia.

New

VBS

AU$0.16

7D

23.1%

1Y

166.7%

Universe Pharmaceuticals

Market Cap: US$4.5m

Through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China.

New

UPC

US$7.05

7D

116.6%

1Y

100.3%

American Green

Market Cap: US$1.1m

Operates as a technology company in the medical cannabis industry in the United States.

ERBB

US$0.0003

7D

20.0%

1Y

0%

Rimrock Gold

Market Cap: US$865.2k

Through its subsidiary, focuses on the development and marketing a line of CBD oils, creams, and hemp extracts.

New

RMRK

US$0.0003

7D

50.0%

1Y

0%

Cannabis Global

Market Cap: US$829.0k

Focuses on the creating and commercialization of engineered technologies to deliver hemp extracts and cannabinoids to the human body.

New

CBGL

US$0.0001

7D

100.0%

1Y

0%

Endonovo Therapeutics

Market Cap: US$180.8k

A biotechnology company, engages in the development, manufacture, and distribution of non-invasive Electroceutical medical devices for regenerative medicine.

New

ENDV

US$0.0001

7D

9,900.0%

1Y

0%

Affymax

Market Cap: US$111.7k

Does not have significant operations.

New

AFFY

US$0.0015

7D

50.0%

1Y

87.5%

Page 1 of 2